Oncotarget

Research Papers:

Melatonin inhibits AP-2β/hTERT, NF-κB/COX-2 and Akt/ERK and activates caspase/Cyto C signaling to enhance the antitumor activity of berberine in lung cancer cells

Jian-Jun Lu _, Lingyi Fu, Zhipeng Tang, Changlin Zhang, Lijun Qin, Jingshu Wang, Zhenlong Yu, Dingbo Shi, Xiangsheng Xiao, Fangyun Xie, Wenlin Huang and Wuguo Deng

PDF  |  HTML  |  How to cite  |  Order a Reprint

Oncotarget. 2016; 7:2985-3001. https://doi.org/10.18632/oncotarget.6407

Metrics: PDF 3062 views  |   HTML 1621 views  |   ?  


Abstract

Jian-Jun Lu1,*, Lingyi Fu2,3,*, Zhipeng Tang4,*, Changlin Zhang2, Lijun Qin5, Jingshu Wang2, Zhenlong Yu4, Dingbo Shi2, Xiangsheng Xiao2, Fangyun Xie2, Wenlin Huang2,6, Wuguo Deng2,6

1Department of Thoracic Surgery, The First Affiliated Hospital, Yat-sen University, Guangzhou, China

2Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China

3Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China

4Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China

5Department of Pediatrics, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China

6State Key Laboratory of Targeted Drug for Tumors of Guangdong Province, Guangzhou Double Bioproduct Inc., Guangzhou, China

*These authors have contributed equally to this article

Correspondence to:

Jian-Jun Lu, e-mail: ljj508@21cn.com

Wuguo Deng, e-mail: dengwg@sysucc.org.cn

Keywords: melantonin, berberine, lung cancer, hTERT, COX-2

Received: August 04, 2015     Accepted: November 16, 2015     Published: November 27, 2015

ABSTRACT

Melatonin, a molecule produced throughout the animal and plant kingdoms, and berberine, a plant derived agent, both exhibit antitumor and multiple biological and pharmacological effects, but they have never been combined altogether for the inhibition of human lung cancers. In this study, we investigated the role and underlying mechanisms of melatonin in the regulation of antitumor activity of berberine in lung cancer cells. Treatment with melatonin effectively increased the berberine-mediated inhibitions of cell proliferation, colony formation and cell migration, thereby enhancing the sensitivities of lung cancer cells to berberine. Melatonin also markedly increased apoptosis induced by berberine. Further mechanism study showed that melatonin promoted the cleavage of caspse-9 and PARP, enhanced the inhibition of Bcl2, and triggered the releasing of cytochrome C (Cyto C), thereby increasing the berberine-induced apoptosis. Melatonin also enhanced the berberine-mediated inhibition of telomerase reverses transcriptase (hTERT) by down-regulating the expression of AP-2β and its binding on hTERT promoter. Moreover, melatonin enhanced the berberine-mediated inhibition of cyclooxygenase 2 (COX-2) by inhibiting the nuclear translocation of NF-κB and its binding on COX-2 promoter. Melatonin also increased the berberine-mediated inhibition of the phosphorylated Akt and ERK. Collectively, our results demonstrated that melatonin enhanced the antitumor activity of berberine by activating caspase/Cyto C and inhibiting AP-2β/hTERT, NF-κB/COX-2 and Akt/ERK signaling pathways. Our findings provide new insights in exploring the potential therapeutic strategies and novel targets for lung cancer treatment.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 6407